Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03041740 · ClinicalTrials.gov registry record · Phase 1
Fluid Filled Lung Oxygenation Assistance Trial
A Phase 1 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT03041740 is a Phase 1 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 16 participants.
The verdict
NCT03041740, a Phase 1 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The primary study objective is to assess the safety and feasibility of perfluorooctylbromide (PFOB) partial liquid ventilation (PLV) in infants with severe Bronchopulmonary Dysplasia (BPD).
Interventions
- DRUG Perfluorooctyl Bromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-06-27 |
| Est. Completion | 2019-06-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03041740
The ClinicalTrials.gov registry entry for NCT03041740 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perfluorooctyl Bromide is the first listed.
NCT03041740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03041740 about?
NCT03041740 is a clinical study titled "Fluid Filled Lung Oxygenation Assistance Trial". The primary study objective is to assess the safety and feasibility of perfluorooctylbromide (PFOB) partial liquid ventilation (PLV) in infants with severe Bronchopulmonary Dysplasia (BPD).
What is the current status of trial NCT03041740?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2017-06-27. Estimated completion is 2019-06-10.
What interventions are being tested in trial NCT03041740?
The interventions under investigation include: Perfluorooctyl Bromide (DRUG).
Who is sponsoring clinical trial NCT03041740?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.